Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,127 | -5,257 | -30,925 | -23,544 | -15,014 |
| Depreciation Amortization | 983 | 478 | 2,044 | 1,540 | 1,034 |
| Accounts receivable | -937 | -567 | -193 | 1,723 | -2,202 |
| Accounts payable and accrued liabilities | -2,159 | -1,085 | 2,305 | 1,282 | 1,595 |
| Other Working Capital | -5,591 | -4,259 | 3,656 | 4,348 | 2,254 |
| Other Operating Activity | 2,881 | 944 | 2,057 | 214 | 2,502 |
| Operating Cash Flow | $-14,950 | $-9,746 | $-21,056 | $-14,437 | $-9,831 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -478 | -362 | -814 | -376 | -160 |
| Investing Cash Flow | $-478 | $-362 | $-814 | $-376 | $-160 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,754 | 5,520 | 20,228 | 7,831 | 6,151 |
| Debt Repayment | -8,799 | -3,261 | -16,128 | -7,391 | -3,767 |
| Common Stock Issued | 34,496 | 21,820 | 8,205 | 8,205 | 8,240 |
| Other Financing Activity | 0 | 0 | -215 | -215 | 0 |
| Financing Cash Flow | $37,451 | $24,079 | $12,090 | $8,430 | $10,624 |
| Beginning Cash Position | 2,833 | 2,833 | 12,613 | 12,613 | 12,613 |
| End Cash Position | 24,856 | 16,804 | 2,833 | 6,230 | 13,246 |
| Net Cash Flow | $22,023 | $13,971 | $-9,780 | $-6,383 | $633 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,950 | -9,746 | -21,056 | -14,437 | -9,831 |
| Capital Expenditure | -478 | -362 | -849 | -391 | -160 |
| Free Cash Flow | -15,428 | -10,108 | -21,905 | -14,828 | -9,991 |